Axcelis Technologies, Inc. Stock News

BEVERLY, Mass., Sept. 21, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be participating in the 23rd International Conference on Silicon Carbide and Related Materials (ICSCRM 2026) taking place September 28 - October 2, 2026, at the Pacifico Yokohama North in Japan.

BEVERLY, Mass., Sept. 14, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be a Platinum Sponsor at the International Conference on Ion Implantation and Annealing Technology 2026 (IIT 2026) taking place September 20-24 at the Congress Center Villach in Austria.

BEVERLY, Mass., Sept. 8, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced plans to invest $35 million in its global manufacturing infrastructure through the construction of a new ion implantation equipment manufacturing facility in Pyeongtaek, Gyeonggi Province, Korea.

Q2 2026 Highlights: Revenue of $215.2 million GAAP Gross Margin of 42.4%, and Non-GAAP Gross Margin of 42.7% GAAP Operating Margin of 9.4% and Non-GAAP Operating Margin of 14.7% GAAP Diluted Earnings Per Share of $0.75, and Non-GAAP Diluted Earnings Per Share of $1.06 BEVERLY, Mass., Aug. 6, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the...

System qualified for emerging PMIC device application requiring advanced 15 MeV implant capability BEVERLY, Mass., July 28, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today the successful Purion XEmax™ high energy implanter evaluation closure at a leading foundry.

BEVERLY, Mass., May 12, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the following upcoming investor conferences: The J.P.

Q1 2026 Highlights: Revenue of $199.0 million GAAP Gross Margin of 40.5%, and Non-GAAP Gross Margin of 40.7% GAAP Operating Margin of 4.0% and Non-GAAP Operating Margin of 11.7% GAAP Diluted Earnings Per Share of $0.30, and Non-GAAP Diluted Earnings Per Share of $0.72   BEVERLY, Mass., May 7, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for th...